Clinical Trials
10 trialsNCT07610616 2026-05-28
Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids
Guangzhou Institute of Respiratory Disease
Recruiting
NCT07052760 2026-04-29
Imaging of Solid Tumors Using DLL3 SPECT
University of California, San Francisco
Phase EARLY_PHASE1 Withdrawn
NCT07474558 2026-03-16
SCARLET-ICE
Jules Bordet Institute
Phase 2 Not yet recruiting
NCT06504719 2025-09-15
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
Hellenic Cooperative Oncology Group
Completed
NCT05011188 2025-08-27
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
University of California, San Francisco
Phase 1/2 Active not recruiting
NCT07051850 2025-07-15
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
Seoul St. Mary's Hospital
Recruiting
NCT06796517 2025-01-28
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
Recruiting
NCT02448420 2024-04-18
PATRICIA II
SOLTI Breast Cancer Research Group
Phase 2 Completed
NCT01841021 2017-01-19
Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT01671813 2013-07-25
Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Withdrawn